Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/55f02155-260f-494a-888c-6aabfd090999/

TTX

Tetratherix Limited
Chart
7.45 AUD
Latest Week 2026-07-31
HealthcareBiotechnologySMALL
Snapshot 2026-07-26 · 1.0w · Fresh
0.11
OS Score
24.0%
Value
22.0%
Quality
24.0%
Momentum
1/9
F-Score
0.230
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
24.0%ile
P/B
13.8×
FCF Yield
-0.009
SH Yield
-0.060
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
76.00000000
/100 — 1=cheapest
VC2 (Trending Value)
76.00000000
/100
VC3 (Buyback)
76.00000000
/100
Negative FCF yield (-0.9%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
22.0%ile
ROE
-0.346
ROA
-0.296
Current
12.24
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
5yr Consist
No
F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
24.0%ile
6M Return
87.1%
12M Return
52.9%
12-1 Mom
31.6%
Risk-Adj
0.44
Vol 252d
72.6%
Vol 60d
143.2%
↑ Expanding
Max DD 12M
-37.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 32% is very strong — a clear uptrend. Near-term vol (143%) is expanding vs long-term (73%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.11
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 145 peers
Sector Value %ile
30.1%
Sector Quality %ile
27.4%
P/B z-score
0.54
Sector Avg OS
43.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 97.0% 89.0%
SDI SDI Limited 96.0% 86.0% 88.0% 96.0%
BP8 BPH Global Ltd 93.0% 81.0% 80.0% 81.0%
AGN Argenica Therapeutics Limited 93.0% 82.0% 80.0% 81.0%
PCK PainChek Limited 89.0% 78.0% 76.0% 77.0%
TRI TrivarX Limited 87.0% 76.0% 75.0% 76.0%
AVH AVITA Medical, Inc. 85.0% 75.0% 73.0% 74.0%
ACL Australian Clinical Labs Limited 85.0% 94.0% 98.0% 12.0%
Factor Interactions
Volatility Expanding
60-day vol (143%) significantly exceeds 252-day (73%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
2.5% avg (3 factors)
Quality
D
33.3% avg (3 factors)
Momentum
A
75.9% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.110—2—
Value %ile0.240—2—
Quality %ile0.220—2—
Momentum %ile0.240—2—
F-Score1.000—8—
Confidence0.258—8—
Volatility0.726—8—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
13.84
FCF Yield
-0.9%
Shareholder Yield
Div + net buyback / mktcap
-6.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-34.6%
Return on Assets
-29.6%
Current Ratio
12.24
External Financing
Net issuance — lower=better
0.858
MomentumPrice trend strength over different horizons
6M Return
87.1%
12M Return
52.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
31.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.44
Growth & StabilityEarnings trajectory, consistency, and capital allocation
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
1
Buyback Yield
-6.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
76
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
76
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
76
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity